Viridian Therapeutics, Inc.

Analyst - Goldman Sachs
All forecasts
Forecast date: 06.06.2024
Expiration date: 03.12.2024
Start price: 14.34 $
Price target: 23 $
Closing price: 14.34 $
Current price: 15.81 $
Closing price 14.34 $ didn't reach the target 23 $ (-37.65%)

Detailed forecast is available by subscription


Subscribe